PER-072-06已完成未知
CHEMOPROPHYLAXIS FOR THE PREVENTION OF HIV IN ME
INSTITUTO NACIONAL DE ALERGIAS Y ENFERMEDADES INFECCIOSAS DE LOS ESTADOS UNIDOS, INSTITUTOS J. DAVID GLADSTONE, FAMILY HEALTH INTERNATIONAL - FHI 360°,0 个研究点目标入组 2,339 人开始时间: 2007年3月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 2,339
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 至 0（—）
入选标准
- •1) Male sex (at birth).
- •2) Ability and willingness to give written informed consent.
- •3) Age equal to or greater than 18 years.
- •4) No presence of infection with HIV-1.
- •5) Evidence of high risk to acquire infection with HIV-1 including one of the following criteria: (1) Not having used a condom during the last receptive and / or insertive anal intercourse with a sexual partner infected with HIV or whose knowledge of HIV infection status is unknown. (2) Have had receptive anal sex with more than 5 sexual partners during the past 6 months. (3) Have exchanged money, gifts, place to spend the night or drugs in exchange for anal sex during the last 6 months. (4) Have been diagnosed with an STI in the last 6 months or at the time of screening. (5) Be a sexual partner of a man infected with HIV, referring to not using condoms consistently.
- •6) Able to provide your address of residence and that of a personal contact.
- •7) Ambulatory performance status ≥ 80 on the Kamofsky scale.
- •9) Adequate renal function evaluated within the first 28 days prior to enrollment.
- •10) Adequate liver function.
- •11) Adequate haematological function.
- •12) Ability to understand and speak Spanish.
排除标准
- •1) Positive result for glucosuria or proteinuria in the urine dipstick test.
- •2) Active or serious infection previously diagnosed.
- •3) History of pathological fractures not related to trauma.
- •4) Consumption of alcohol or drugs considered sufficient to prevent compliance with any of the study procedures.
- •5) Upon enrollment, if there is any condition that may interfere with the participant s ability to provide informed consent, make their participation in the study unsafe, complicate the interpretation of the results, or otherwise interfere with the ability to reach the results of the study.
研究者
相似试验
终止
4 期
Implementation of Human Immunodeficiency Virus (HIV) pre-exposure prophylaxis with antiretroviral medications amongst men at high risk for HIV infection; a demonstration projectHIV preventionInfection - Acquired immune deficiency syndrome (AIDS / HIV)Public Health - Other public healthACTRN12615000032550Cairns and Hinterland Hospital and Health Service3,000
招募中
不适用
PROJECT ¿SABES?”PER-066-14Centro de Investigacion del Cancer Fred Hutchinson, Estados Unidos,2,138
未知
不适用
HIV TESTING AND TREATMENT TO PREVENT ONWARD HIV TRANSMISSION AMONG FOR MEN WHO HAVE SEX WITH MEN AND TRANSGENDER WOMEN IN LIMA, PERPER-095-12Centro de Investigacion del Cancer Fred Hutchinson, Estados Unidos,
进行中（未招募）
不适用
HIV prevention for men who have sex with men using medicatioprevention of HIV infectionEUCTR2014-002569-32-NLAcademic Medical Center
已完成
不适用
AMPrEP (Amsterdam PrEP project)HIVpreventionPre-exposure prophylaxisNL-OMON22706Academic Medical Center is sponsor. Center for study visits: Public Health service Amsterdam (GGD Amsterdam)370